Patent · US Active

Treatment of hyperproliferative diseases with vinca alkaloid N-oxide and analogs

US8048872B2 · kind B2 · utility

1Cited by

9References

22Claims

0Family size

Assignee

Stat of Oregon Acting by and Through The Oregon State Board of Higher Education on Behalf of the University of Oregon · US

Inventors

John G. Curd · Hillsborough, US
John F. W. Keana · Eugene, US
Alshad S. Lalani · Briarcliff Manor, US
Paul B. Westberg · San Mateo, US
Bradford Goodwin · San Mateo, US
W. David Henner · Tucson, US

Key dates

Filing date	Apr 29, 2008
Grant date	Nov 1, 2011
Priority date	—
Expiry date	Mar 14, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to vinca alkaloid and analog N-oxides having activity for treating hyperproliferative disorders. Further, the invention relates to pharmaceutical compositions and methods of using vinca alkaloid and analog N-oxides, alone or in combination with one or more other active agents or treatments, to treat hyperproliferative disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.